KOPP INVESTMENT ADVISORS LLC - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 85 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q3 2014. The put-call ratio across all filers is 2.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
KOPP INVESTMENT ADVISORS LLC ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q4 2015$931,000
-21.5%
315,293
-16.0%
0.46%
-28.2%
Q3 2015$1,186,000
-48.4%
375,293
-3.3%
0.64%
-37.6%
Q2 2015$2,297,000
-70.2%
388,000
-46.2%
1.02%
-70.0%
Q1 2015$7,703,000
+8.2%
720,553
-5.0%
3.41%
-0.4%
Q4 2014$7,119,000
+16.6%
758,233
-4.6%
3.42%
+13.3%
Q3 2014$6,103,000
+7.1%
794,658
+25.2%
3.02%
+15.3%
Q2 2014$5,701,000634,7532.62%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q3 2014
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 2,484,649$7,330,0008.59%
Avoro Capital Advisors LLC 5,144,916$15,178,0005.23%
Broadfin Capital, LLC 6,090,829$17,968,0001.10%
Aisling Capital LLC 2,010,000$5,930,0001.02%
Healthcare Value Capital, LLC 150,000$443,0000.73%
ACUTA CAPITAL PARTNERS, LLC 434,300$1,281,0000.61%
WALL STREET ASSOCIATES 696,300$2,054,0000.58%
SEARLE & CO. 172,500$500,0000.48%
Elk Creek Partners, LLC 2,253,667$6,648,0000.47%
KOPP INVESTMENT ADVISORS LLC 315,293$931,0000.46%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders